High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection
about
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trialsTargeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyInvestigational drugs to treat methicillin-resistant Staphylococcus aureusWill there ever be a universal Staphylococcus aureus vaccine?Development of a vaccine against Staphylococcus aureusCurrent concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureusThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.The bicomponent pore-forming leucocidins of Staphylococcus aureusProduction of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection.Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?Frequency of panton-valentine leukocidin-producing methicillin-sensitive Staphylococcus strains in patients with complicated skin and soft tissue infection in bronx, new york.Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin InfectionSublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.Typing of Panton-Valentine Leukocidin-Encoding Phages and lukSF-PV Gene Sequence Variation in Staphylococcus aureus from ChinaPrevention and treatment of Staphylococcus aureus biofilms.Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB.Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection.Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children.The levels of antibodies to Panton-Valentine leukocidin (PVL) vary with PVL prevalence along a north-to-south gradient.Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia.[Panton-Valentine leukocidin in patients with chronic wounds. Results from a clinical investigation in 100 patients].Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain.Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection.Catching the evader: Can monoclonal antibodies interfere with Staphylococcus aureus immune escape?Characterization of recombinant wild-type and nontoxigenic protein A from Staphylococcus pseudintermedius
P2860
Q21131308-C0A6A5F4-E884-4F1D-B759-CBBCB6FAF265Q26752975-1C9A807E-AC7F-4179-968E-8790AB567CF3Q26780246-5466BBA7-2D23-4F86-9C07-B6EE9C82612EQ26824837-A7C2CB76-0D73-4BC5-AE43-ABFDB0AB0D02Q27015365-BF4B730D-D0B5-4214-8FCA-B6F919C67AEBQ27023330-00EBAEC4-D654-49CE-B714-41276CA20687Q30415990-4AF5F1BC-BDEC-40D3-9B5A-87917FF50AC4Q33743499-ADC8FB80-8F3B-421A-AE6F-67FCAE5C45C5Q34075795-4DDF14D6-739E-4702-8E9D-616FF0FDD00EQ34533083-DB4672CA-23D1-47FD-8D58-89701FE45684Q35020067-127501CC-CA99-496D-8004-FCD86DF67E17Q35139743-3FE48158-3B46-4E55-AD6D-FA3E3C8A859FQ35947359-99BC67DB-7A16-4E5F-8E0E-70A9C94BE0DCQ36091286-2B16629A-F71B-4D74-9753-10893974D705Q36159649-35A2BF05-B14D-453B-AF6F-385BC9B89389Q36211152-BC9812FD-9355-4E55-AE35-FB51B9B7424BQ36811244-88134F46-B84E-4876-B125-11DE85580755Q36970896-6DC6D685-E1DA-4826-A0FD-5AEA64AC195FQ36979233-313E5019-A90A-48C9-87FF-A2010F2B9414Q37148705-1DB74A42-AF89-41D6-ADB1-B8BF13D8A195Q37482155-3892C588-C73F-405F-81CE-14EAAE178D93Q37643858-BAC8519A-28E7-4CC5-9C11-4CC28DF3FD8FQ37878489-0752E3FA-E597-4685-9250-4CE63F3C1F3CQ38145284-2121CE3F-85BA-4EB6-BEB6-7B78A5DB6AE4Q38193690-DDC7E09E-743D-4E85-8F87-17C60912EC6FQ38728618-FC455778-2EAF-4A5C-A205-1E89AAEB4912Q39249431-C8F02319-23DA-4EF1-AA39-3CDB3316FEB4Q39384894-D75FFE48-747E-4A7C-A2E5-C3441D62FCC3Q42254590-FB5AF4B0-57A9-46E2-A3A9-84699F18BEA2Q43749119-435BBB27-3D18-49E3-A80E-6C52C2D9642CQ47098119-C8EB9E31-D042-4C8B-9079-1497B9A717D6Q52657370-66BC32EA-2509-4734-BC02-BCBC7B6D6FD7Q54400618-530A8CB4-A693-4564-A5B1-CB87EF0C6669Q57176627-814DAC87-8C7D-41B2-83D5-CBE3FBA2FC5B
P2860
High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High levels of antibody to pan ...... skin and soft-tissue infection
@ast
High levels of antibody to pan ...... skin and soft-tissue infection
@en
High levels of antibody to pan ...... skin and soft-tissue infection
@nl
type
label
High levels of antibody to pan ...... skin and soft-tissue infection
@ast
High levels of antibody to pan ...... skin and soft-tissue infection
@en
High levels of antibody to pan ...... skin and soft-tissue infection
@nl
prefLabel
High levels of antibody to pan ...... skin and soft-tissue infection
@ast
High levels of antibody to pan ...... skin and soft-tissue infection
@en
High levels of antibody to pan ...... skin and soft-tissue infection
@nl
P2093
P2860
P356
P1476
High levels of antibody to pan ...... skin and soft-tissue infection
@en
P2093
Christina R Hermos
Gerald B Pier
Pauline Yoong
P2860
P304
P356
10.1086/656742
P407
P577
2010-10-14T00:00:00Z